Perclose ProGlide Suture-Mediated Closure System

PRECAUTIONS
Provides the security of suture for vascular closure of 5F - 21F femoral artery access sites. For Sheath sizes greater than 8F, at least two devices and the pre-close technique are required.

Perclose ProGlide® 6F Suture-Mediated Closure (SMC) System
INDICATIONS
The Perclose ProGlide SMC System is indicated for the percutaneous delivery of suture for closing the common femoral artery access site of patients who have undergone diagnostic or interventional catheterization procedures using 5F to 21F sheaths. For sheath sizes greater than 8F, at least two devices and the pre-close technique are required.

CAUTION
Federal law restricts this device to sale by or on the order of a physician (or allied healthcare professionals, authorized by, or under the direction of, such physicians) who is trained in diagnostic and/or interventional catheterization procedures and who has been trained by an authorized representative of Abbott Vascular.
Prior to use, the operator must review the Instructions for Use and be familiar with the deployment techniques associated with the use of this device.
During closure of arteriotomy sites using an 8.5F-21F procedural sheath, which requires the use of at least two devices, it is recommended that a vascular surgeon or a surgeon with vascular training be available in case surgical conversion to control bleeding and to close the arteriotomy is needed.

CONTRAINDICATIONS
There are no known contraindications to the use of this device. Attention is drawn to the WARNINGS AND PRECAUTIONS SECTION.

WARNINGS
Do not use the Perclose ProGlide SMC device or accessories if the packaging or sterile barrier has been previously opened or damaged or if the components appear to be damaged or defective.
DO NOT RESTERILIZE OR REUSE. The Perclose ProGlide SMC device and accessories are intended for single use only.
Do not use the Perclose ProGlide SMC System if the sterile field has been broken where bacterial contamination of the sheath or surrounding tissues may have occurred, since such a broken sterile field may result in infection.
Do not use the Perclose ProGlide SMC System if the puncture site is located above the most inferior border of the inferior epigastric artery (IEA) and/or above the inguinal ligament based upon bony landmarks, since such a puncture site may result in a retroperitoneal hematoma. Perform a femoral angiogram to verify the location of the puncture site. NOTE: This may require both a Right Anterior Oblique (RAO) and Left Anterior Oblique (LAO) angiogram to adequately visualize where the sheath enters the femoral artery.
Do not use the Perclose ProGlide SMC System if the puncture is through the posterior wall or if there are multiple punctures, since such punctures may result in a hematoma or retroperitoneal bleed.
Do not use the Perclose ProGlide SMC System if the puncture site is located in the superficial femoral artery or the profunda femoris artery, or the bifurcation of these vessels, since such puncture sites may result in a pseudoaneurysm, intimal dissection, or an acute vessel closure (thrombosis of small artery lumen). Perform a femoral angiogram to verify the location of the puncture site. NOTE: This may require both a Right Anterior Oblique (RAO) and Left Anterior Oblique (LAO) angiogram to adequately visualize where the sheath enters the femoral artery.

PRECAUTIONS
1. Prior to use, inspect the Perclose ProGlide SMC System to ensure that the sterile packaging has not been damaged during shipment. Examine all components prior to use to verify proper function. Exercise care during device handling to reduce the possibility of accidental device breakage.

2. As with all catheter-based procedures, infection is a possibility. Observe sterile technique at all times when using the Perclose ProGlide SMC System. Employ appropriate groin management post procedure and post hospital discharge to prevent infection.

3. Use a single wall puncture technique. Do not puncture the posterior wall of the artery.

4. Do not deploy the Perclose ProGlide SMC device at an angle greater than 45 degrees as this may cause a cuff miss.

5. There are no reaccess restrictions if previous arteriotomy repairs were achieved with Abbott Vascular SMC devices.

6. If significant blood flow is present around the Perclose ProGlide SMC device, do not deploy needles. Remove the Perclose ProGlide SMC device over a 0.038” (or smaller) guide wire and insert an appropriately sized introducer sheath.

7. When pushing the plunger assembly to advance the needles, stabilize the device to ensure the device does not twist or move forward during deployment. Twisting the device could lead to needle deflection resulting in a cuff miss. Do not use excessive force or repeatedly push the plunger assembly. Excessive force on the plunger during deployment could potentially cause breakage of the device, which may necessitate intervention and/or surgical removal of the device and vessel repair.

8. Do not apply excessive force to the lever when returning the foot to its original position (marked #4) down to the body of the device. Do not attempt to remove the device without closing the lever. Excessive force on the lever of the device or attempting to remove the device without closing the lever could cause breakage of the device and/or lead to vessel trauma, which may necessitate intervention and/or surgical removal of the device and vessel repair.

9. Do not advance or withdraw the Perclose ProGlide SMC device against resistance until the cause of that resistance has been determined (see IFU SMC DEVICE PLACEMENT sections). Excessive force used to advance or torque the Perclose ProGlide SMC device should be avoided, as this may lead to significant vessel damage and/or breakage of the device, which may necessitate intervention and/or surgical removal of the device and vessel repair.

10. If excessive resistance in advancing the Perclose ProGlide SMC device is encountered, withdraw the device over a 0.038” (or smaller) guide wire and reinsert the introducer sheath or use manual compression.

11. Remove the Perclose ProGlide sheath before tightening the suture. Failure to remove the sheath prior to tightening the suture may result in detachment of the tip of the sheath.

12. In using this or any other suture material, care should be taken to avoid damage from handling. Avoid crushing damage due to application of surgical instruments such as forceps or needle holders. 13. During closure of arteriotomy sites using a 5F-8F procedural sheath, use manual compression in the event that bleeding from the femoral access site persists after the use of the Perclose ProGlide SMC device.

14. During closure of arteriotomy sites using an 8.5F-21F procedural sheath, in the event that bleeding from the femoral access site persists after the use of the Perclose ProGlide SMC devices, the physician should assess the situation. Based on the physician assessment of the amount of bleeding use manual compression, compression assisted devices and/or a surgical repair to obtain hemostasis.

15. During closure of arteriotomy sites using an 8.5F-21F procedural sheath, in those cases where the implanting physician is not a vascular surgeon, it is recommended that a vascular surgeon or a surgeon with vascular training be available during the procedure to perform any necessary surgical intervention.

POTENTIAL ADVERSE EVENTS

Potential complications associated with suture mediated closure devices may include, but are not limited to, the following: ·Allergic reaction or hypersensitivity to device components · Anemia · Arterial stenosis/occlusion ·Arteriovenous fistula · Bleeding/hemorrhage · Bruising/hematoma · Death · Deep vein thrombosis · Device entrapment · Device failure /malfunction/misplacement · Diminished pulses distal to closure site · Embolism · Extended Hospitalization / Delayed time to ambulation · Infection/sepsis · Inflammation · Intimal tear/dissection · Ischemia distal to closure site · Nerve injury · Numbness · Pain · Perforation · Pseudoaneurysm · Retroperitional hematoma/bleeding · Surgical exposure/closure of common femoral artery · Thrombus formation · Vascular injury · Vasovagal episode · Vasoconstriction/vasospasm · Wound dehiscence

Prior to use, please reference the Instructions for Use at www.abbottvascular.com/ifu for more information on indications, contraindications, warnings, precautions, and adverse events.